Skip to main content
Top
Published in: BMC Ophthalmology 1/2018

Open Access 01-12-2018 | Research article

Two-year topographic and densitometric outcomes of accelerated (45 mW/cm2) transepithelial corneal cross-linking for keratoconus: a case-control study

Authors: Jinrong Huang, Yang Shen, Weijun Jian, Haipeng Xu, Meiyan Li, Jing Zhao, Xingtao Zhou, Hongfei Liao

Published in: BMC Ophthalmology | Issue 1/2018

Login to get access

Abstract

Background

Conventional corneal cross-linking is effective for retarding the progression of keratoconus. However the long-term efficacy and safety of accelerated (45 mW/cm2) transepithelial corneal cross-linking (ATE-CXL) on progressive keratoconus (KC) treatment is not fully understood. The purpose of this study is to evaluate the 2-year changes in corneal topographic parameters and densitometry values after ATE-CXL for KC.

Methods

Twenty-five progressive eyes of 25 KC patients (KC group) and 25 eyes of 25 myopes without KC (control group) were enrolled. Corneal topography and densitometry values were evaluated pre-operatively and at 6, 12 and 24 months post-operatively in the KC group.

Results

The mean values of flat keratometry (K1), steep keratometry (K2), mean keratometry (Km), corneal astigmatism (CA), maximum keratometry (Kmax), central corneal thickness (CCT), thinnest corneal thickness (TCT), anterior corneal elevation (ACE) and posterior corneal elevation (PCE) all remained unchanged over time (all P values > 0.05). The densitometry values of the anterior, central, posterior and total layers over the annular diameters 0 mm to 2 mm (Φ0-2 mm) and Φ2–6 mm all decreased significantly (all P values < 0.05). At post-operative month 24, except for the densitometry value of the posterior layer (Φ0-2 mm), which was significantly lower than that of the control group (post hoc P = 0.010), all densitometry values obtained from the remaining locations of the KC eyes were equal to those of the control group (All post hoc P values > 0.05). Subgroups with Km ≥ 50.30D or ACE ≥35.3 μm progressed significantly when compared with those with Km < 50.30D (F = 8.167, P = 0.004) or ACE< 35.3 μm (F = 5.207, P = 0.022).

Conclusions

K1, K2, Km, CA, Kmax, CCT, TCT, ACE, and PCE values may remain stable but severer KC patients tend to have poorer long-term outcomes. The densitometry values of the full corneal thickness (total layer over Φ0-2 mm and Φ2–6 mm) may decrease to normal levels at 2 years after ATE-CXL for KC.
Literature
1.
go back to reference Galvis V, Sherwin T, Tello A, Merayo J, Barrera R, Acera A. Keratoconus: an inflammatory disorder? Eye (Lond). 2015;29(7):843–59.CrossRef Galvis V, Sherwin T, Tello A, Merayo J, Barrera R, Acera A. Keratoconus: an inflammatory disorder? Eye (Lond). 2015;29(7):843–59.CrossRef
2.
go back to reference Mrazovac D, Barisić Kutija M, Vidas S, et al. Contact lenses as the best conservative treatment of newly diagnosed keratoconus--epidemiological retrospective study. Coll Antropol. 2014;38(4):1115–8.PubMed Mrazovac D, Barisić Kutija M, Vidas S, et al. Contact lenses as the best conservative treatment of newly diagnosed keratoconus--epidemiological retrospective study. Coll Antropol. 2014;38(4):1115–8.PubMed
3.
go back to reference Hellstedt T, Mäkelä J, Uusitalo R, Emre S, Uusitalo R. Treating keratoconus with intacs corneal ring segments. J Refract Surg. 2005;21(3):236–46.PubMed Hellstedt T, Mäkelä J, Uusitalo R, Emre S, Uusitalo R. Treating keratoconus with intacs corneal ring segments. J Refract Surg. 2005;21(3):236–46.PubMed
4.
go back to reference Richard JM, Paton D. Gasset AR. A comparison of penetrating keratoplasty and lamellar keratoplasty in the surgical management of keratoconus. Am J Ophthalmol. 1978;86(6):807–11.CrossRef Richard JM, Paton D. Gasset AR. A comparison of penetrating keratoplasty and lamellar keratoplasty in the surgical management of keratoconus. Am J Ophthalmol. 1978;86(6):807–11.CrossRef
5.
go back to reference Wood TO. Lamellar transplants in keratoconus. Am J Ophthalmol. 1977;83(4):543–5.CrossRef Wood TO. Lamellar transplants in keratoconus. Am J Ophthalmol. 1977;83(4):543–5.CrossRef
6.
go back to reference Cannon DJ, Foster CS. Collagen crosslinking in keratoconus. Invest Ophthalmol Vis Sci. 1978;17(1):63–5.PubMed Cannon DJ, Foster CS. Collagen crosslinking in keratoconus. Invest Ophthalmol Vis Sci. 1978;17(1):63–5.PubMed
7.
go back to reference Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–7.CrossRef Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–7.CrossRef
8.
go back to reference Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/ UVA. Cornea. 2004;23(5):503–7.CrossRef Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/ UVA. Cornea. 2004;23(5):503–7.CrossRef
9.
go back to reference Beshtawi IM, O'Donnell C, Radhakrishnan H. Biomechanical properties of corneal tissue after ultraviolet-A-riboflavin crosslinking. J Cataract Refract Surg. 2013;39(3):451–62.CrossRef Beshtawi IM, O'Donnell C, Radhakrishnan H. Biomechanical properties of corneal tissue after ultraviolet-A-riboflavin crosslinking. J Cataract Refract Surg. 2013;39(3):451–62.CrossRef
10.
go back to reference Mencucci R, Marini M, Paladini I, et al. Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea. Clin Exp Ophthalmol. 2010;38(1):49–56.CrossRef Mencucci R, Marini M, Paladini I, et al. Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea. Clin Exp Ophthalmol. 2010;38(1):49–56.CrossRef
11.
go back to reference Greenstein SA, Fry KL, Bhatt J, et al. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: scheimpflug and biomicroscopic analysis. J Cataract Refract Surg. 2010;36(12):2105–14.CrossRef Greenstein SA, Fry KL, Bhatt J, et al. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: scheimpflug and biomicroscopic analysis. J Cataract Refract Surg. 2010;36(12):2105–14.CrossRef
12.
go back to reference Caporossi A, Mazzotta C, Baiocchi S, et al. Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol. 2010;149(4):585–93.CrossRef Caporossi A, Mazzotta C, Baiocchi S, et al. Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol. 2010;149(4):585–93.CrossRef
13.
go back to reference Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009;35(8):1358–62.CrossRef Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009;35(8):1358–62.CrossRef
14.
go back to reference Leccisotti A, Islam T. Transepithelial corneal collagen cross-linking in keratoconus. J Refract Surg. 2010;26(12):942–8.CrossRef Leccisotti A, Islam T. Transepithelial corneal collagen cross-linking in keratoconus. J Refract Surg. 2010;26(12):942–8.CrossRef
15.
go back to reference Shen Y, Jian W, Sun L, et al. One-year follow-up of changes in corneal densitometry after accelerated (45 mW/cm2) Transepithelial corneal collagen cross-linking for keratoconus: a retrospective study. Cornea. 2016;35(11):1434–40.CrossRef Shen Y, Jian W, Sun L, et al. One-year follow-up of changes in corneal densitometry after accelerated (45 mW/cm2) Transepithelial corneal collagen cross-linking for keratoconus: a retrospective study. Cornea. 2016;35(11):1434–40.CrossRef
16.
go back to reference Otri AM, Fares U, Al-Aqaba MA, Dua HS. Corneal densitometry as an indicator of corneal health. Ophthalmology. 2012;119(3):501–8.CrossRef Otri AM, Fares U, Al-Aqaba MA, Dua HS. Corneal densitometry as an indicator of corneal health. Ophthalmology. 2012;119(3):501–8.CrossRef
17.
go back to reference Vinciguerra P, Randleman JB, Romano V, et al. Transepithelial iontophoresis corneal collagen cross-linking for progressive keratoconus: initial clinical outcomes. J Refract Surg. 2014;30(11):746–53.CrossRef Vinciguerra P, Randleman JB, Romano V, et al. Transepithelial iontophoresis corneal collagen cross-linking for progressive keratoconus: initial clinical outcomes. J Refract Surg. 2014;30(11):746–53.CrossRef
18.
go back to reference Chan TC, Chow VW, Jhanji V, et al. Different topographic response between mild to moderate and advanced keratoconus after accelerated collagen cross-linking. Cornea. 2015;34(8):922–7.CrossRef Chan TC, Chow VW, Jhanji V, et al. Different topographic response between mild to moderate and advanced keratoconus after accelerated collagen cross-linking. Cornea. 2015;34(8):922–7.CrossRef
19.
go back to reference Freegard TJ. The physical basis of transparency of the normal cornea. Eye (Lond). 1997;11(Pt 4):465–71.CrossRef Freegard TJ. The physical basis of transparency of the normal cornea. Eye (Lond). 1997;11(Pt 4):465–71.CrossRef
20.
go back to reference Ng AL, Chan TC, Cheng AC. Conventional versus accelerated corneal collagen cross-linking in the treatment of keratoconus. Clin Exp Ophthalmol. 2016;44(1):8–14.CrossRef Ng AL, Chan TC, Cheng AC. Conventional versus accelerated corneal collagen cross-linking in the treatment of keratoconus. Clin Exp Ophthalmol. 2016;44(1):8–14.CrossRef
21.
go back to reference Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin crosslinking of the cornea. Cornea. 2007;26(4):385–9.CrossRef Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin crosslinking of the cornea. Cornea. 2007;26(4):385–9.CrossRef
22.
go back to reference Wollensak G, Spoerl E, Wilsch M, Seiler T. Endothelial cell damage after riboflavin-ultraviolet-a treatment in the rabbit. J Cataract Refract Surg. 2003;29(9):1786–90.CrossRef Wollensak G, Spoerl E, Wilsch M, Seiler T. Endothelial cell damage after riboflavin-ultraviolet-a treatment in the rabbit. J Cataract Refract Surg. 2003;29(9):1786–90.CrossRef
23.
go back to reference Hashemi H, Seyedian MA, Miraftab M, Fotouhi A, Asgari S. Corneal collagen cross-linking with riboflavin and ultraviolet a irradiation for keratoconus: long-term results. Ophthalmology. 2013;120(8):1515–2.CrossRef Hashemi H, Seyedian MA, Miraftab M, Fotouhi A, Asgari S. Corneal collagen cross-linking with riboflavin and ultraviolet a irradiation for keratoconus: long-term results. Ophthalmology. 2013;120(8):1515–2.CrossRef
24.
go back to reference Magli A, Forte R, Tortori A, Capasso L, Marsico G, Piozzi E. Epithelium-off corneal collagen cross-linking versus transepithelial cross-linking for pediatric keratoconus. Cornea. 2013;32(5):597–601.CrossRef Magli A, Forte R, Tortori A, Capasso L, Marsico G, Piozzi E. Epithelium-off corneal collagen cross-linking versus transepithelial cross-linking for pediatric keratoconus. Cornea. 2013;32(5):597–601.CrossRef
25.
go back to reference Shetty R, Pahuja NK, Nuijts RM, et al. Current Protocols of Corneal Collagen Cross-Linking: Visual, Refractive, and Tomographic Outcomes. Am J Ophthalmol. 2015;160(2):243–9.CrossRef Shetty R, Pahuja NK, Nuijts RM, et al. Current Protocols of Corneal Collagen Cross-Linking: Visual, Refractive, and Tomographic Outcomes. Am J Ophthalmol. 2015;160(2):243–9.CrossRef
26.
go back to reference Medeiros CS, Giacomin NT, Bueno RL, Ghanem RC, Moraes HV Jr, Santhiago MR. Accelerated corneal collagen crosslinking: technique, efficacy, safety, and applications. J Cataract Refract Surg. 2016;42(12):1826–35.CrossRef Medeiros CS, Giacomin NT, Bueno RL, Ghanem RC, Moraes HV Jr, Santhiago MR. Accelerated corneal collagen crosslinking: technique, efficacy, safety, and applications. J Cataract Refract Surg. 2016;42(12):1826–35.CrossRef
27.
go back to reference Olivo-Payne A, Serna-Ojeda JC, Hernandez-Bogantes E, et al. Trans-epithelial accelerated corneal cross-linking for keratoconus in children. Int J Ophthalmol. 2017;10(12):1919–21.PubMedPubMedCentral Olivo-Payne A, Serna-Ojeda JC, Hernandez-Bogantes E, et al. Trans-epithelial accelerated corneal cross-linking for keratoconus in children. Int J Ophthalmol. 2017;10(12):1919–21.PubMedPubMedCentral
28.
go back to reference Peyman A, Kamali A, Khushabi M, et al. Collagen cross-linking effect on progressive keratoconus in patients younger than 18 years of age: a clinical trial. Adv Biomed Res. 2015;23(4):245.CrossRef Peyman A, Kamali A, Khushabi M, et al. Collagen cross-linking effect on progressive keratoconus in patients younger than 18 years of age: a clinical trial. Adv Biomed Res. 2015;23(4):245.CrossRef
29.
go back to reference Bao F, Geraghty B, Wang Q, Elsheikh A. Consideration of corneal biomechanics in the diagnosis and management of keratoconus: is it important? Eye Vis (Lond). 2016;3:18.CrossRef Bao F, Geraghty B, Wang Q, Elsheikh A. Consideration of corneal biomechanics in the diagnosis and management of keratoconus: is it important? Eye Vis (Lond). 2016;3:18.CrossRef
30.
go back to reference Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28(4):293–322.CrossRef Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28(4):293–322.CrossRef
Metadata
Title
Two-year topographic and densitometric outcomes of accelerated (45 mW/cm2) transepithelial corneal cross-linking for keratoconus: a case-control study
Authors
Jinrong Huang
Yang Shen
Weijun Jian
Haipeng Xu
Meiyan Li
Jing Zhao
Xingtao Zhou
Hongfei Liao
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2018
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-018-0999-4

Other articles of this Issue 1/2018

BMC Ophthalmology 1/2018 Go to the issue